Fri Jun 13 11:50:00 UTC 2025: **Summary:**

Several biotech stocks experienced significant price fluctuations in pre-market trading on Thursday (as of 8:20 am ET). Healthcare Triangle, Inc. saw the largest gain, soaring over 152%. Other notable gainers included Klotho Neurosciences, CureVac N.V., and Liminatus Pharma, Inc.. Conversely, Intensity Therapeutics, Inc. plummeted, dropping by 49%, followed by Helius Medical Technologies, Inc. and Catheter Precision, Inc.. Economic news from the U.S., Canada, Europe, and Asia also factored into this week’s movements.

**News Article:**

**Biotech Stocks See Volatile Pre-Market Trading; Several Firms Surge While Others Plunge**

**[City, State] –** The biotech sector witnessed a flurry of activity in pre-market trading Thursday, with several companies experiencing dramatic price swings. As of 8:20 am ET, Healthcare Triangle, Inc. (HCTI) led the charge, rocketing over 152% to $0.02. Other prominent gainers included Klotho Neurosciences, Inc. (KLTO), up over 42% at $2.05, CureVac N.V. (CVAC), climbing over 31% to $5.36, and Liminatus Pharma, Inc. (LIMN), rising over 18% to $13.11.

However, not all biotech firms shared in the positive momentum. Intensity Therapeutics, Inc. (INTS) suffered a steep decline, plummeting 49% to $0.29. Helius Medical Technologies, Inc. (HSDT) also took a significant hit, falling 44% to $0.62, followed by Catheter Precision, Inc. (VTAK) decreasing 29% to $0.43.

This week’s market activity was also influenced by broader economic news. In the U.S., investors digested survey data and official reports on manufacturing and the labor market. Canada’s policy decision announcement garnered attention, while the European Central Bank’s rate decision was the main focus in Europe. In Asia, private sector survey data from China attracted scrutiny amid ongoing trade tariff uncertainty.

Investors are advised to exercise caution and conduct thorough research before making any investment decisions in the volatile biotech sector.

Read More